These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12751269)

  • 1. Ensuring supplies of quality diethylcarbamazine citrate (DEC).
    Kitler ME; Zagaria N
    J Clin Pharmacol; 2003 May; 43(5):477-90. PubMed ID: 12751269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high performance liquid chromatographic method for the estimation of diethylcarbamazine content in medicated salt samples.
    Mathew N; Kalyanasundaram M
    Acta Trop; 2001 Oct; 80(2):97-102. PubMed ID: 11600085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the chemotherapy of lymphatic filariasis.
    Navaratnam V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 2():51-4. PubMed ID: 7973948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
    Koyadun S; Bhumiratana A; Prikchu P
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India.
    Kerketta AS; Babu BV; Swain BK
    Acta Trop; 2007 Jun; 102(3):159-64. PubMed ID: 17553441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compendial issues: WHO.
    Kopp-Kubel S
    J Parenter Sci Technol; 1992; 46(6):201-5. PubMed ID: 1474431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
    Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
    Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid method to assess the coverage of the mass drug administration of diethylcarbamazine in the program to eliminate lymphatic filariasis in India.
    Babu BV
    Southeast Asian J Trop Med Public Health; 2005 Jan; 36(1):44-5. PubMed ID: 15906640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of seven rounds of mass administration of diethylcarbamazine and ivermectin on prevalence of chronic lymphatic filariasis in south India.
    Yuvaraj J; Pani SP; Vanamail P; Ramaiah KD; Das PK
    Trop Med Int Health; 2008 May; 13(5):737-42. PubMed ID: 18346027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
    Regu K; Showkath Ali MK; Rajendran R; Koya SM; Ganesh B; Dhariwal AC; Lal S
    J Commun Dis; 2006 Dec; 38(4):333-8. PubMed ID: 17913209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-tech analytical method for diethylcarbamazine citrate in medicated salt.
    Weaver A; Brown P; Huey S; Magallon M; Bollman EB; Mares D; Streit TG; Lieberman M
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e1005. PubMed ID: 21347443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' management of filarial lymphoedema and hydrocele in Pondicherry, India.
    Schellekens SM; Ananthakrishnan S; Stolk WA; Habbema JD; Ravi R
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):75-7. PubMed ID: 15550265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.